Pharmaresearch Bio Co (XKRX:217950) Net Change in Cash : ₩24,680 Mil (TTM As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Pharmaresearch Bio Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Pharmaresearch Bio Co's Net Change in Cash for the six months ended in Dec. 2024 was ₩24,680 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 was ₩24,680 Mil.

Pharmaresearch Bio Co Net Change in Cash Historical Data

The historical data trend for Pharmaresearch Bio Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaresearch Bio Co Net Change in Cash Chart

Pharmaresearch Bio Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Change in Cash

Get a 7-Day Free Trial

-546.53

7,915.49

327.09

929.12

24,679.87

Pharmaresearch Bio Co Semi-Annual Data
	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
Net Change in Cash	Get a 7-Day Free Trial			-546.53	7,915.49	327.09	929.12	24,679.87

Pharmaresearch Bio Co Net Change in Cash Calculation

Pharmaresearch Bio Co's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	11640.599	+	4264.988	+	8774.287	+	0
	=	24,680

Pharmaresearch Bio Co's Net Change in Cash for the quarter that ended in Dec. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 11640.599 + 4264.988 + 8774.287 + 0

= 24,680

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 was ₩24,680 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmaresearch Bio Co Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Pharmaresearch Bio Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmaresearch Bio Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaresearch Bio Co Ltd (XKRX:217950) » Definitions » Net Change in Cash

Comparable Companies

XKRX:456070 XKRX:083790 XKRX:376270 XKRX:060590 XKRX:174900 XKRX:234690 XKRX:353810 XKRX:278650 XKRX:214260 XKRX:217730 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270

Traded in Other Exchanges

N/A

Address

641-3, Saimdang-ro, Gangwon-do, Gangneung-si, KOR, 13494

Website

http://www.pr-bio.co.kr

Pharmaresearch Bio Co Ltd is a Korea-based biopharmaceutical company. The company is engaged in the research and development, manufacturing, sale, and marketing of biopharmaceutical products. Its product is ReNTox Injections, and Clostridium Botulinum Toxin type A is in pipeline.

Pharmaresearch Bio Co Headlines

No Headlines